Back

Drug Pricing Summary

NADAC

$0.2381 - $1.3451

VA FSS

$0.3258 - $1.9050

VA Big4

$1.1682

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
desipramine hydrochloride 100 mg (TABLET) $1.1181 VA FSS
  • Desipramine Hydrochloride (100)
  • Sandoz, Inc.
    desipramine hydrochloride 10 mg (TABLET) $0.2642 NADAC generic
  • DESIPRAMINE HYDROCHLORIDE (1)
  • Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    desipramine hydrochloride 10 mg (TABLET) $0.3258 VA FSS
  • Desipramine Hydrochloride (100)
  • Sandoz, Inc.
    desipramine hydrochloride 10 mg (TABLET) $0.5167 NADAC generic
  • Desipramine Hydrochloride (1)
  • Amneal Pharmaceuticals NY LLC
    desipramine hydrochloride 10 mg (TABLET) $1.1682 VA Big4
  • Norpramin (100)
  • Validus Pharmaceuticals LLC
    desipramine hydrochloride 10 mg (TABLET) $1.1682 VA FSS
  • Norpramin (100)
  • Validus Pharmaceuticals LLC
    desipramine hydrochloride 150 mg (TABLET) $1.9050 VA FSS
  • Desipramine Hydrochloride (50)
  • Sandoz, Inc.
    desipramine hydrochloride 25 mg (TABLET) $0.2381 NADAC generic
  • DESIPRAMINE HYDROCHLORIDE (1)
  • Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    desipramine hydrochloride 25 mg (TABLET) $0.4679 VA FSS
  • Desipramine Hydrochloride (100)
  • Sandoz, Inc.
    desipramine hydrochloride 50 mg (TABLET) $0.6602 VA FSS
  • Desipramine Hydrochloride (100)
  • Sandoz, Inc.
    desipramine hydrochloride 50 mg (TABLET) $1.3451 NADAC generic
  • DESIPRAMINE HYDROCHLORIDE (1)
  • Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    desipramine hydrochloride 75 mg (TABLET) $1.0005 VA FSS
  • Desipramine Hydrochloride (100)
  • Sandoz, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue